258 related items for PubMed ID: 25239302
1. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ.
Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
[Abstract] [Full Text] [Related]
2. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
[Abstract] [Full Text] [Related]
3. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
[Abstract] [Full Text] [Related]
4. Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies
.
Hansrivijit P, Puthenpura MM, Ghahramani N.
Clin Nephrol; 2020 Sep; 94(3):117-126. PubMed ID: 32589135
[Abstract] [Full Text] [Related]
5. Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept
.
Dado D, Parikh S, Ayoub I, Rovin B, Nadasdy T, Hebert L.
Clin Nephrol; 2018 May; 89(5):376-380. PubMed ID: 29249233
[Abstract] [Full Text] [Related]
6. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
Gong X, Huang J, Zhang Y, Wang F, Wang X, Meng L, Cheng X, Liu G, Cui Z, Zhao M.
Ren Fail; 2023 May; 45(2):2279642. PubMed ID: 37942512
[Abstract] [Full Text] [Related]
7. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
Ahmed HM, Ezzat DA, Doudar NA, Adel M.
Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
[Abstract] [Full Text] [Related]
8. Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?
Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH.
Pediatr Nephrol; 2014 Dec; 29(12):2333-40. PubMed ID: 25017621
[Abstract] [Full Text] [Related]
9. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.
Sci Rep; 2018 Nov 23; 8(1):17322. PubMed ID: 30470792
[Abstract] [Full Text] [Related]
10. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
Pediatr Nephrol; 2018 Jul 23; 33(7):1183-1187. PubMed ID: 29569191
[Abstract] [Full Text] [Related]
11. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
Mishra OP, Chhabra P, Narayan G, Srivastava P, Prasad R, Singh A, Abhinay A, Batra VV.
Indian J Pediatr; 2019 Jan 23; 86(1):26-31. PubMed ID: 29968132
[Abstract] [Full Text] [Related]
12. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
Eroglu FK, Orhan D, İnözü M, Duzova A, Gulhan B, Ozaltin F, Topaloglu R.
Pediatr Int; 2019 Dec 23; 61(12):1250-1256. PubMed ID: 31513327
[Abstract] [Full Text] [Related]
13. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.
Eur J Clin Invest; 2015 Apr 23; 45(4):394-404. PubMed ID: 25682967
[Abstract] [Full Text] [Related]
14. Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.
Burke GW, Chandar J, Sageshima J, Ortigosa-Goggins M, Amarapurkar P, Mitrofanova A, Defreitas MJ, Katsoufis CP, Seeherunvong W, Centeno A, Pagan J, Mendez-Castaner LA, Mattiazzi AD, Kupin WL, Guerra G, Chen LJ, Morsi M, Figueiro JMG, Vianna R, Abitbol CL, Roth D, Fornoni A, Ruiz P, Ciancio G, Garin EH.
Pediatr Nephrol; 2023 Jan 23; 38(1):145-159. PubMed ID: 35507150
[Abstract] [Full Text] [Related]
15. Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.
Rivard CJ, Tanabe T, Lanaspa MA, Watanabe H, Nomura S, Andres-Hernando A, Garth K, Sekijima M, Ishimoto T, Ariyoshi Y, Garcia GE, Shah J, Lennan B, Tasaki M, Pomposelli T, Shimizu A, Sachs DH, Johnson RJ, Yamada K.
Transpl Int; 2018 Oct 23; 31(10):1164-1177. PubMed ID: 29722117
[Abstract] [Full Text] [Related]
16. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
Expert Opin Investig Drugs; 2018 Nov 23; 27(11):839-879. PubMed ID: 30360670
[Abstract] [Full Text] [Related]
17. Urinary fibrinogen and renal tubulointerstitial fibrinogen deposition: Discriminating between primary FSGS and minimal change disease.
Wang Y, Zheng C, Xu F, Liu Z.
Biochem Biophys Res Commun; 2016 Sep 23; 478(3):1147-52. PubMed ID: 27539323
[Abstract] [Full Text] [Related]
18. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V, López D, Boixadera E, Ibernón M, Espinal A, Bonet J, Romero R.
BMC Nephrol; 2017 Feb 03; 18(1):49. PubMed ID: 28158993
[Abstract] [Full Text] [Related]
19. [The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].
Li YH, Huang HC, Liu G, Zhang YK.
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr 03; 36(2):135-8. PubMed ID: 15100729
[Abstract] [Full Text] [Related]
20. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
